HCPCS Range Drugs, Administered by Injection

• 1 Injection, tetracycline, up to 250 mg ( J0120 )

• 2 Injection, abatacept, 10 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) ( J0129 )

• 3 Injection abciximab, 10 mg ( J0130 )

• 4 Injection, acetaminophen, not otherwise specified,10 mg ( J0131 )

• 5 Injection, acetylcysteine, 100 mg ( J0132 )

• 6 Injection, acyclovir, 5 mg ( J0133 )

• 7 Injection, adalimumab, 20 mg ( J0135 )

• 8 Injection, Adrenalin, epinephrine, 0.1 mg ( J0171 )

• 9 Injection, aflibercept, 1 mg ( J0178 )

• 10 Injection, agalsidase beta, 1 mg ( J0180 )

• 11 Injection, biperiden lactate, per 5 mg ( J0190 )

• 12 Injection, alatrofloxacin mesylate, 100 mg ( J0200 )

• 13 Injection, alglucerase, per 10 units ( J0205 )

• 14 Injection, amifostine, 500 mg ( J0207 )

• 15 Injection, methyldopate HCl, up to 250 mg ( J0210 )

• 16 Injection, alefacept, 0.5 mg ( J0215 )

• 17 Injection, alglucosidase alfa, 10 mg, not otherwise specified ( J0220 )

• 18 Injection, alglucosidase alfa, (Lumizyme), 10 mg ( J0221 )

• 19 Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg ( J0256 )

• 20 Injection, alpha 1 proteinase inhibitor (human), (GLASSIA), 10 mg ( J0257 )

• 21 Injection, alprostadil, 1.25 mcg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) ( J0270 )

• 22 Alprostadil urethral suppository (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) ( J0275 )

• 23 Injection, amikacin sulfate, 100 mg ( J0278 )

• 24 Injection, aminophyllin, up to 250 mg ( J0280 )

• 25 Injection, amiodarone hydrochloride, 30 mg ( J0282 )

• 26 Injection, amphotericin B, 50 mg ( J0285 )

• 27 Injection, amphotericin B lipid complex, 10 mg ( J0287 )

• 28 Injection, amphotericin B cholesteryl sulfate complex, 10 mg ( J0288 )

• 29 Injection, amphotericin B liposome, 10 mg ( J0289 )

• 30 Injection, ampicillin sodium, 500 mg ( J0290 )

• 31 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm ( J0295 )

• 32 Injection, amobarbital, up to 125 mg ( J0300 )

• 33 Injection, succinylcholine chloride, up to 20 mg ( J0330 )

• 34 Injection, anidulafungin, 1 mg ( J0348 )

• 35 Injection, anistreplase, per 30 units ( J0350 )

• 36 Injection, hydralazine HCl, up to 20 mg ( J0360 )

• 37 Injection, apomorphine hydrochloride, 1 mg ( J0364 )

• 38 Injection, aprotinin, 10, 000 kiu ( J0365 )

• 39 Injection, metaraminol bitartrate, per 10 mg ( J0380 )

• 40 Injection, chloroquine hydrochloride, up to 250 mg ( J0390 )

• 41 Injection, arbutamine HCl, 1 mg ( J0395 )

• 42 Injection, aripiprazole, intramuscular, 0.25 mg ( J0400 )

• 43 Injection, aripiprazole (abilify maintena), 1 mg ( J0401 )

• 44 Injection, azithromycin, 500 mg ( J0456 )

• 45 Injection, atropine sulfate, 0.01 mg ( J0461 )

• 46 Injection, dimercaprol, per 100 mg ( J0470 )

• 47 Injection, baclofen, 10 mg ( J0475 )

• 48 Injection, baclofen, 50 mcg for intrathecal trial ( J0476 )

• 49 Injection, basiliximab, 20 mg ( J0480 )

• 50 Injection, belatacept, 1 mg ( J0485 )

• 51 Injection, belimumab, 10 mg ( J0490 )

• 52 Injection, dicyclomine HCl, up to 20 mg ( J0500 )

• 53 Injection, benztropine mesylate, per 1 mg ( J0515 )

• 54 Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg ( J0520 )

• 55 Injection, penicillin G benzathine and penicillin G procaine, 100, 000 units ( J0558 )

• 56 Injection, penicillin G benzathine, 100, 000 units ( J0561 )

• 57 Buprenorphine implant, 74.2 mg ( J0570 )

• 58 Injection, bivalirudin, 1 mg ( J0583 )

• 59 Injection, onabotulinumtoxinA, 1 unit ( J0585 )

• 60 Injection, abobotulinumtoxinA, 5 Units ( J0586 )

• 61 Injection, rimabotulinumtoxinB, 100 units ( J0587 )

• 62 Injection, incobotulinumtoxinA, 1 unit ( J0588 )

• 63 Injection, buprenorphine hydrochloride, 0.1 mg ( J0592 )

• 64 Injection, Busulfan, 1 mg ( J0594 )

• 65 Injection, butorphanol tartrate, 1 mg ( J0595 )

• 66 Injection, C-1 esterase inhibitor (human), Berinert, 10 units ( J0597 )

• 67 Injection, C-1 esterase inhibitor (human), Cinryze, 10 units ( J0598 )

• 68 Injection, edetate calcium disodium, up to 1000 mg ( J0600 )

• 69 Injection, calcium glycerophosphate and calcium lactate, per 10 ml ( J0620 )

• 70 Injection, calcitonin salmon, up to 400 units ( J0630 )

• 71 Injection, calcitriol, 0.1 mcg ( J0636 )

• 72 Injection, caspofungin acetate, 5 mg ( J0637 )

• 73 Injection, canakinumab, 1 mg ( J0638 )

• 74 Injection, leucovorin calcium, per 50 mg ( J0640 )

• 75 Injection, levoleucovorin, not otherwise specified, 0.5 mg ( J0641 )

• 76 Injection, mepivacaine hydrochloride, per 10 ml ( J0670 )

• 77 Injection, cefazolin sodium, 500 mg ( J0690 )

• 78 Injection, cefepime hydrochloride, 500 mg ( J0692 )

• 79 Injection, cefoxitin sodium, 1 gm ( J0694 )

• 80 Injection, ceftriaxone sodium, per 250 mg ( J0696 )

• 81 Injection, sterile cefuroxime sodium, per 750 mg ( J0697 )

• 82 Injection, cefotaxime sodium, per gm ( J0698 )

• 83 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg ( J0702 )

• 84 Injection, Caffeine Citrate, 5 mg ( J0706 )

• 85 Injection, cephapirin sodium, up to 1 gm ( J0710 )

• 86 Injection, ceftaroline fosamil, 10 mg ( J0712 )

• 87 Injection, ceftazidime, per 500 mg ( J0713 )

• 88 Injection, ceftizoxime sodium, per 500 mg ( J0715 )

• 89 Injection, centruroides immune f(ab)2, up to 120 milligrams ( J0716 )

• 90 Injection, certolizumab pegol, 1 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) ( J0717 )

• 91 Injection, chloramphenicol sodium succinate, up to 1 gm ( J0720 )

• 92 Injection, chorionic gonadotropin, per 1, 000 USP units ( J0725 )

• 93 Injection, clonidine hydrochloride, 1 mg ( J0735 )

• 94 Injection, cidofovir, 375 mg ( J0740 )

• 95 Injection, cilastatin sodium; imipenem, per 250 mg ( J0743 )

• 96 Injection, ciprofloxacin for intravenous infusion, 200 mg ( J0744 )

• 97 Injection, codeine phosphate, per 30 mg ( J0745 )

• 98 Injection, colistimethate sodium, up to 150 mg ( J0770 )

• 99 Injection, collagenase, clostridium histolyticum, 0.01 mg ( J0775 )

• 100 Injection, prochlorperazine, up to 10 mg ( J0780 )

• 101 Injection, corticorelin ovine triflutate, 1 microgram ( J0795 )

• 102 Injection, cosyntropin, 0.25 mg ( J0834 )

• 103 Injection, crotalidae polyvalent immune FAB(Ovine), up to 1 gram ( J0840 )

• 104 Injection, cytomegalovirus immune globulin intravenous (human), per vial ( J0850 )

• 105 Injection, daptomycin, 1 mg ( J0878 )

• 106 Injection, darbepoetin alfa, 1 microgram (non-ESRD use) ( J0881 )

• 107 Injection, darbepoetin alfa, 1 microgram (for ESRD on dialysis) ( J0882 )

• 108 Injection, epoetin alfa, (for non-ESRD use), 1000 units ( J0885 )

• 109 Injection, peginesatide, 0.1 mg (for ESRD on dialysis) ( J0890 )

• 110 Injection, decitabine, 1 mg ( J0894 )

• 111 Injection, deferoxamine mesylate, 500 mg ( J0895 )

• 112 Injection, denosumab, 1 mg ( J0897 )

• 113 Injection, brompheniramine maleate, per 10 mg ( J0945 )

• 114 Injection, depo-estradiol cypionate, up to 5 mg ( J1000 )

• 115 Injection, medroxyprogesterone acetate, 1 mg ( J1050 )

• 116 Injection, dexamethasone acetate, 1 mg ( J1094 )

• 117 Injection, dexamethasone sodium phosphate, 1 mg ( J1100 )

• 118 Injection, dihydroergotamine mesylate, per 1 mg ( J1110 )

• 119 Injection, acetazolamide sodium, up to 500 mg ( J1120 )

• 120 Injection, digoxin, up to 0.5 mg ( J1160 )

• 121 Injection, digoxin immune FAB(Ovine), per vial ( J1162 )

• 122 Injection, phenytoin sodium, per 50 mg ( J1165 )

• 123 Injection, hydromorphone, up to 4 mg ( J1170 )

• 124 Injection, dyphylline, up to 500 mg ( J1180 )

• 125 Injection, dexrazoxane hydrochloride, per 250 mg ( J1190 )

• 126 Injection, diphenhydramine HCl, up to 50 mg ( J1200 )

• 127 Injection, chlorothiazide sodium, per 500 mg ( J1205 )

• 128 Injection, DMSO, dimethyl sulfoxide, 50%, 50 ml ( J1212 )

• 129 Injection, methadone HCl, up to 10 mg ( J1230 )

• 130 Injection, dimenhydrinate, up to 50 mg ( J1240 )

• 131 Injection, dipyridamole, per 10 mg ( J1245 )

• 132 Injection, Dobutamine hydrochloride, per 250 mg ( J1250 )

• 133 Injection, dolasetron mesylate, 10 mg ( J1260 )

• 134 Injection, dopamine HCl, 40 mg ( J1265 )

• 135 Injection, doripenem, 10 mg ( J1267 )

• 136 Injection, doxercalciferol, 1 mcg ( J1270 )

• 137 Injection, ecallantide, 1 mg ( J1290 )

• 138 Injection, eculizumab, 10 mg ( J1300 )

• 139 Injection, amitriptyline HCl, up to 20 mg ( J1320 )

• 140 Injection, enfuvirtide, 1 mg ( J1324 )

• 141 Injection, epoprostenol, 0.5 mg ( J1325 )

• 142 Injection, eptifibatide, 5 mg ( J1327 )

• 143 Injection, ergonovine maleate, up to 0.2 mg ( J1330 )

• 144 Injection, ertapenem sodium, 500 mg ( J1335 )

• 145 Injection, erythromycin lactobionate, per 500 mg ( J1364 )

• 146 Injection, estradiol valerate, up to 10 mg ( J1380 )

• 147 Injection, estrogen conjugated, per 25 mg ( J1410 )

• 148 Injection, ethanolamine oleate, 100 mg ( J1430 )

• 149 Injection, estrone, per 1 mg ( J1435 )

• 150 Injection, etidronate disodium, per 300 mg ( J1436 )

• 151 Injection, etanercept, 25 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) ( J1438 )

• 152 Fecal microbiota, live - jslm, 1 ml ( J1440 )

• 153 Injection, filgrastim (G-CSF), excludes biosimilars, 1 microgram ( J1442 )

• 154 Injection fluconazole, 200 mg ( J1450 )

• 155 Injection, fomepizole, 15 mg ( J1451 )

• 156 Injection, fomivirsen sodium, intraocular, 1.65 mg ( J1452 )

• 157 Injection, fosaprepitant, 1 mg ( J1453 )

• 158 Injection, foscarnet sodium, per 1000 mg ( J1455 )

• 159 Injection, gallium nitrate, 1 mg ( J1457 )

• 160 Injection, galsulfase, 1 mg ( J1458 )

• 161 Injection, immune globulin (Privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg ( J1459 )

• 162 Injection, gamma globulin, intramuscular, 1 cc ( J1460 )

• 163 Injection, immune globulin (bivigam), 500 mg ( J1556 )

• 164 Injection, immune globulin, (Gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg ( J1557 )

• 165 Injection, immune globulin (Hizentra), 100 mg ( J1559 )

• 166 Injection, gamma globulin, intramuscular, over 10 cc ( J1560 )

• 167 Injection, immune globulin, (Gamunex-C/Gammaked), non-lyophilized (e.g., liquid), 500 mg ( J1561 )

• 168 Injection, immune globulin (Vivaglobin), 100 mg ( J1562 )

• 169 Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg ( J1566 )

• 170 Injection, immune globulin, (Octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg ( J1568 )

• 171 Injection, immune globulin, (Gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg ( J1569 )

• 172 Injection, ganciclovir sodium, 500 mg ( J1570 )

• 173 Injection, hepatitis B immune globulin (HepaGam B), intramuscular, 0.5 ml ( J1571 )

• 174 Injection, immune globulin, (Flebogamma/Flebogamma Dif), intravenous, non-lyophilized (e.g., liquid), 500 mg ( J1572 )

• 175 Injection, hepatitis B immune globulin (HepaGam B), intravenous, 0.5 ml ( J1573 )

• 176 Injection, garamycin, gentamicin, up to 80 mg ( J1580 )

• 177 Injection, glatiramer acetate, 20 mg ( J1595 )

• 178 Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg ( J1599 )

• 179 Injection, gold sodium thiomalate, up to 50 mg ( J1600 )

• 180 Injection, golimumab, 1 mg, for intravenous use ( J1602 )

• 181 Injection, glucagon hydrochloride, per 1 mg ( J1610 )

• 182 Injection, gonadorelin hydrochloride, per 100 mcg ( J1620 )

• 183 Injection, granisetron hydrochloride, 100 mcg ( J1626 )

• 184 Injection, haloperidol, up to 5 mg ( J1630 )

• 185 Injection, haloperidol decanoate, per 50 mg ( J1631 )

• 186 Injection, hemin, 1 mg ( J1640 )

• 187 Injection, heparin sodium, (heparin lock flush), per 10 units ( J1642 )

• 188 Injection, heparin sodium, per 1000 units ( J1644 )

• 189 Injection, dalteparin sodium, per 2500 IU ( J1645 )

• 190 Injection, enoxaparin sodium, 10 mg ( J1650 )

• 191 Injection, fondaparinux sodium, 0.5 mg ( J1652 )

• 192 Injection, tinzaparin sodium, 1000 IU ( J1655 )

• 193 Injection, tetanus immune globulin, human, up to 250 units ( J1670 )

• 194 Injection, histrelin acetate, 10 micrograms ( J1675 )

• 195 Injection, hydrocortisone acetate, up to 25 mg ( J1700 )

• 196 Injection, hydrocortisone sodium phosphate, up to 50 mg ( J1710 )

• 197 Injection, hydrocortisone sodium succinate, up to 100 mg ( J1720 )

• 198 Injection, diazoxide, up to 300 mg ( J1730 )

• 199 Injection, ibandronate sodium, 1 mg ( J1740 )

• 200 Injection, ibuprofen, 100 mg ( J1741 )

• 201 Injection, ibutilide fumarate, 1 mg ( J1742 )

• 202 Injection, idursulfase, 1 mg ( J1743 )

• 203 Injection, icatibant, 1 mg ( J1744 )

• 204 Injection, infliximab, excludes biosimilar, 10 mg ( J1745 )

• 205 Injection, iron dextran, 50 mg ( J1750 )

• 206 Injection, iron sucrose, 1 mg ( J1756 )

• 207 Injection, imiglucerase, 10 units ( J1786 )

• 208 Injection, droperidol, up to 5 mg ( J1790 )

• 209 Injection, propranolol HCl, up to 1 mg ( J1800 )

• 210 Injection, droperidol and fentanyl Citrate, up to 2 ml ampule ( J1810 )

• 211 Injection, insulin, per 5 units ( J1815 )

• 212 Insulin for administration through DME (i.e., insulin pump) per 50 units ( J1817 )

• 213 Injection, interferon beta-1a, 30 mcg ( J1826 )

• 214 Injection interferon beta-1b, 0.25 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) ( J1830 )

• 215 Injection, itraconazole, 50 mg ( J1835 )

• 216 Injection, ketorolac tromethamine, per 15 mg ( J1885 )

• 217 Injection, cephalothin sodium, up to 1 gram ( J1890 )

• 218 Injection, lanreotide, 1 mg ( J1930 )

• 219 Injection, laronidase, 0.1 mg ( J1931 )

• 220 Injection, furosemide, up to 20 mg ( J1940 )

• 221 Injection, lepirudin, 50 mg ( J1945 )

• 222 Injection, leuprolide acetate (for depot suspension), per 3.75 mg ( J1950 )

• 223 Injection, levetiracetam, 10 mg ( J1953 )

• 224 Injection, levocarnitine, per 1 gm ( J1955 )

• 225 Injection, levofloxacin, 250 mg ( J1956 )

• 226 Injection, levorphanol tartrate, up to 2 mg ( J1960 )

• 227 Injection, hyoscyamine sulfate, up to 0.25 mg ( J1980 )

• 228 Injection, chlordiazepoxide HCl, up to 100 mg ( J1990 )

• 229 Injection, lidocaine HCl for intravenous infusion, 10 mg ( J2001 )

• 230 Injection, lincomycin HCl, up to 300 mg ( J2010 )

• 231 Injection, linezolid, 200 mg ( J2020 )

• 232 Injection, lorazepam, 2 mg ( J2060 )

• 233 Injection, mannitol, 25% in 50 ml ( J2150 )

• 234 Injection, mecasermin, 1 mg ( J2170 )

• 235 Injection, meperidine hydrochloride, per 100 mg ( J2175 )

• 236 Injection, meperidine and promethazine HCl, up to 50 mg ( J2180 )

• 237 Injection, meropenem, 100 mg ( J2185 )

• 238 Injection, methylergonovine maleate, up to 0.2 mg ( J2210 )

• 239 Injection, methylnaltrexone, 0.1 mg ( J2212 )

• 240 Injection, micafungin sodium, 1 mg ( J2248 )

• 241 Injection, midazolam hydrochloride, per 1 mg ( J2250 )

• 242 Injection, milrinone lactate, 5 mg ( J2260 )

• 243 Injection, minocycline hydrochloride, 1 mg ( J2265 )

• 244 Injection, morphine sulfate, up to 10 mg ( J2270 )

• 245 Injection, ziconotide, 1 microgram ( J2278 )

• 246 Injection, moxifloxacin, 100 mg ( J2280 )

• 247 Injection, nalbuphine hydrochloride, per 10 mg ( J2300 )

• 248 Injection, naloxone hydrochloride, per 1 mg ( J2310 )

• 249 Injection, naltrexone, depot form, 1 mg ( J2315 )

• 250 Injection, nandrolone decanoate, up to 50 mg ( J2320 )

• 251 Injection, natalizumab, 1 mg ( J2323 )

• 252 Injection, nesiritide, 0.1 mg ( J2325 )

• 253 Injection, octreotide, depot form for intramuscular injection, 1 mg ( J2353 )

• 254 Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg ( J2354 )

• 255 Injection, oprelvekin, 5 mg ( J2355 )

• 256 Injection, omalizumab, 5 mg ( J2357 )

• 257 Injection, olanzapine, long-acting, 1 mg ( J2358 )

• 258 Injection, orphenadrine citrate, up to 60 mg ( J2360 )

• 259 Injection, ondansetron hydrochloride, per 1 mg ( J2405 )

• 260 Injection, oxymorphone HCl, up to 1 mg ( J2410 )

• 261 Injection, palifermin, 50 micrograms ( J2425 )

• 262 Injection, paliperidone palmitate extended release (invega sustenna), 1 mg ( J2426 )

• 263 Injection, pamidronate disodium, per 30 mg ( J2430 )

• 264 Injection, papaverine HCl, up to 60 mg ( J2440 )

• 265 Injection, oxytetracycline HCl, up to 50 mg ( J2460 )

• 266 Injection, palonosetron HCl, 25 mcg ( J2469 )

• 267 Injection, paricalcitol, 1 mcg ( J2501 )

• 268 Injection, pegaptanib sodium, 0.3 mg ( J2503 )

• 269 Injection, pegademase bovine, 25 IU ( J2504 )

• 270 Injection, pegloticase, 1 mg ( J2507 )

• 271 Injection, penicillin G procaine, aqueous, up to 600, 000 units ( J2510 )

• 272 Injection, pentastarch, 10% solution, 100 ml ( J2513 )

• 273 Injection, pentobarbital sodium, per 50 mg ( J2515 )

• 274 Injection, penicillin G potassium, up to 600, 000 units ( J2540 )

• 275 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) ( J2543 )

• 276 Pentamidine isethionate, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, per 300 mg ( J2545 )

• 277 Injection, promethazine HCl, up to 50 mg ( J2550 )

• 278 Injection, phenobarbital sodium, up to 120 mg ( J2560 )

• 279 Injection, plerixafor, 1 mg ( J2562 )

• 280 Injection, oxytocin, up to 10 units ( J2590 )

• 281 Injection, desmopressin acetate, per 1 mcg ( J2597 )

• 282 Injection, prednisolone acetate, up to 1 ml ( J2650 )

• 283 Injection, tolazoline HCl, up to 25 mg ( J2670 )

• 284 Injection, progesterone, per 50 mg ( J2675 )

• 285 Injection, fluphenazine decanoate, up to 25 mg ( J2680 )

• 286 Injection, procainamide HCl, up to 1 gm ( J2690 )

• 287 Injection, oxacillin sodium, up to 250 mg ( J2700 )

• 288 Injection, neostigmine methylsulfate, up to 0.5 mg ( J2710 )

• 289 Injection, protamine sulfate, per 10 mg ( J2720 )

• 290 Injection, protein C concentrate, intravenous, human, 10 IU ( J2724 )

• 291 Injection, protirelin, per 250 mcg ( J2725 )

• 292 Injection, pralidoxime chloride, up to 1 gm ( J2730 )

• 293 Injection, phentolamine mesylate, up to 5 mg ( J2760 )

• 294 Injection, metoclopramide HCl, up to 10 mg ( J2765 )

• 295 Injection, quinupristin/dalfopristin, 500 mg (150/350) ( J2770 )

• 296 Injection, ranibizumab, 0.1 mg ( J2778 )

• 297 Injection, rasburicase, 0.5 mg ( J2783 )

• 298 Injection, regadenoson, 0.1 mg ( J2785 )

• 299 Injection, Rho D immune globulin, human, minidose, 50 micrograms (250 IU) ( J2788 )

• 300 Injection, Rho D immune globulin, human, full dose, 300 micrograms (1500 IU) ( J2790 )

• 301 Injection, Rho D immune globulin (human), (Rhophylac), intramuscular or intravenous, 100 IU ( J2791 )

• 302 Injection, Rho D immune globulin, intravenous, human, solvent detergent, 100 IU ( J2792 )

• 303 Injection, rilonacept, 1 mg ( J2793 )

• 304 Injection, risperidone (risperdal consta), 0.5 mg ( J2794 )

• 305 Injection, ropivacaine hydrochloride, 1 mg ( J2795 )

• 306 Injection, romiplostim, 10 micrograms ( J2796 )

• 307 Injection, methocarbamol, up to 10 ml ( J2800 )

• 308 Injection, sincalide, 5 micrograms ( J2805 )

• 309 Injection, theophylline, per 40 mg ( J2810 )

• 310 Injection, sargramostim (GM-CSF), 50 mcg ( J2820 )

• 311 Injection, secretin, synthetic, human, 1 microgram ( J2850 )

• 312 Injection, aurothioglucose, up to 50 mg ( J2910 )

• 313 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg ( J2916 )

• 314 Injection, somatrem, 1 mg ( J2940 )

• 315 Injection, somatropin, 1 mg ( J2941 )

• 316 Injection, promazine HCl, up to 25 mg ( J2950 )

• 317 Injection, reteplase, 18.1 mg ( J2993 )

• 318 Injection, streptokinase, per 250, 000 IU ( J2995 )

• 319 Injection, alteplase recombinant, 1 mg ( J2997 )

• 320 Injection, streptomycin, up to 1 gm ( J3000 )

• 321 Injection, fentanyl Citrate, 0.1 mg ( J3010 )

• 322 Injection, sumatriptan succinate, 6 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) ( J3030 )

• 323 Injection, taliglucerase alfa, 10 units ( J3060 )

• 324 Injection, pentazocine, 30 mg ( J3070 )

• 325 Injection, telavancin, 10 mg ( J3095 )

• 326 Injection, tenecteplase, 1 mg ( J3101 )

• 327 Injection, terbutaline sulfate, up to 1 mg ( J3105 )

• 328 Injection, teriparatide, 10 mcg ( J3110 )

• 329 Injection, chlorpromazine HCl, up to 50 mg ( J3230 )

• 330 Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial ( J3240 )

• 331 Injection, tigecycline, 1 mg ( J3243 )

• 332 Injection, tirofiban HCl, 0.25mg ( J3246 )

• 333 Injection, trimethobenzamide HCl, up to 200 mg ( J3250 )

• 334 Injection, tobramycin sulfate, up to 80 mg ( J3260 )

• 335 Injection, tocilizumab, 1 mg ( J3262 )

• 336 Injection, torsemide, 10 mg/ml ( J3265 )

• 337 Injection, thiethylperazine maleate, up to 10 mg ( J3280 )

• 338 Injection, treprostinil, 1 mg ( J3285 )

• 339 Injection, triamcinolone acetonide, preservative free, 1 mg ( J3300 )

• 340 Injection, triamcinolone acetonide, not otherwise specified, 10 mg ( J3301 )

• 341 Injection, triamcinolone diacetate, per 5 mg ( J3302 )

• 342 Injection, triamcinolone hexacetonide, per 5 mg ( J3303 )

• 343 Injection, trimetrexate glucuronate, per 25 mg ( J3305 )

• 344 Injection, perphenazine, up to 5 mg ( J3310 )

• 345 Injection, triptorelin pamoate, 3.75 mg ( J3315 )

• 346 Injection, spectinomycin dihydrochloride, up to 2 gm ( J3320 )

• 347 Injection, urea, up to 40 gm ( J3350 )

• 348 Injection, urofollitropin, 75 IU ( J3355 )

• 349 Ustekinumab, for subcutaneous injection, 1 mg ( J3357 )

• 350 Injection, diazepam, up to 5 mg ( J3360 )

• 351 Injection, urokinase, 5000 IU vial ( J3364 )

• 352 Injection, IV, urokinase, 250, 000 IU vial ( J3365 )

• 353 Injection, vancomycin HCl, 500 mg ( J3370 )

• 354 Injection, velaglucerase alfa, 100 units ( J3385 )

• 355 Injection, verteporfin, 0.1 mg ( J3396 )

• 356 Injection, triflupromazine HCl, up to 20 mg ( J3400 )

• 357 Injection, hydroxyzine HCl, up to 25 mg ( J3410 )

• 358 Injection, thiamine HCl, 100 mg ( J3411 )

• 359 Injection, pyridoxine HCl, 100 mg ( J3415 )

• 360 Injection, vitamin B-12 cyanocobalamin, up to 1000 mcg ( J3420 )

• 361 Injection, phytonadione (vitamin K), per 1 mg ( J3430 )

• 362 Injection, voriconazole, 10 mg ( J3465 )

• 363 Injection, hyaluronidase, up to 150 units ( J3470 )

• 364 Injection, hyaluronidase, ovine, preservative free, per 1 USP unit (up to 999 USP units) ( J3471 )

• 365 Injection, hyaluronidase, ovine, preservative free, per 1000 USP units ( J3472 )

• 366 Injection, hyaluronidase, recombinant, 1 USP unit ( J3473 )

• 367 Injection, magnesium sulfate, per 500 mg ( J3475 )

• 368 Injection, potassium chloride, per 2 mEq ( J3480 )

• 369 Injection, zidovudine, 10 mg ( J3485 )

• 370 Injection, ziprasidone mesylate, 10 mg ( J3486 )

• 371 Injection, zoledronic acid, 1 mg ( J3489 )

• 372 Unclassified drugs ( J3490 )

• 373 Edetate disodium, per 150 mg ( J3520 )

• 374 Nasal vaccine inhalation ( J3530 )

• 375 Drug administered through a metered dose inhaler ( J3535 )

• 376 Laetrile, amygdalin, vitamin B17 ( J3570 )

• 377 Unclassified biologics ( J3590 )

• 378 Infusion, normal saline solution , 1000 cc ( J7030 )

• 379 Infusion, normal saline solution, sterile (500 ml=1 unit) ( J7040 )

• 380 5% dextrose/normal saline (500 ml = 1 unit) ( J7042 )

• 381 Infusion, normal saline solution , 250 cc ( J7050 )

• 382 5% dextrose/water (500 ml = 1 unit) ( J7060 )

• 383 Infusion, D5W, 1000 cc ( J7070 )

• 384 Infusion, dextran 40, 500 ml ( J7100 )

• 385 Infusion, dextran 75, 500 ml ( J7110 )

• 386 Ringers lactate infusion, up to 1000 cc ( J7120 )

• 387 Hypertonic saline solution, 1 ml ( J7131 )

• 388 Injection, levothyroxine sodium, not otherwise specified, 10 mcg ( J0650 )

• 389 Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv) ( J0750 )

• 390 Injection, methylprednisolone acetate, 1 mg ( J1010 )

• 391 Injection, diclofenac sodium, 0.5 mg ( J1130 )

• 392 Injection, labetalol hydrochloride, 5 mg ( J1920 )

• 393 Injection, sebelipase alfa, 1 mg ( J2840 )

• 394 Injection, ocrelizumab, 1 mg ( J2350 )

• 395 Injection, dexamethasone 9 percent, intraocular, 1 microgram ( J1095 )

• 396 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) ( J0153 )

• 397 Buprenorphine, oral, 1 mg ( J0571 )

• 398 Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine ( J0572 )

• 399 Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine ( J0573 )

• 400 Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine ( J0574 )

• 401 Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine ( J0575 )

• 402 Injection, epoetin beta, 1 microgram, (for ESRD on dialysis) ( J0887 )

• 403 Injection, epoetin beta, 1 microgram, (for Non ESRD use) ( J0888 )

• 404 Injection, testosterone cypionate, 1 mg ( J1071 )

• 405 Injection, elosulfase alfa, 1 mg ( J1322 )

• 406 Injection, ferric carboxymaltose, 1 mg ( J1439 )

• 407 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg ( J2274 )

• 408 Injection, propofol, 10 mg ( J2704 )

• 409 Injection, testosterone enanthate, 1 mg ( J3121 )

• 410 Injection, testosterone undecanoate, 1 mg ( J3145 )

• 411 Injection, pasireotide long acting, 1 mg ( J2502 )

• 412 Injection, peramivir, 1 mg ( J2547 )

• 413 Injection, siltuximab, 10 mg ( J2860 )

• 414 Injection, tedizolid phosphate, 1 mg ( J3090 )

• 415 Injection, vedolizumab, intravenous, 1 mg ( J3380 )

• 416 5% dextrose in lactated ringers infusion, up to 1000 cc ( J7121 )

• 417 Injection, oritavancin (orbactiv), 10 mg ( J2407 )

• 418 Injection, immune globulin/hyaluronidase, (HYQVIA), 100 mg immuneglobulin ( J1575 )

• 419 Injection, isavuconazonium, 1 mg ( J1833 )

• 420 Injection, alemtuzumab, 1 mg ( J0202 )

• 421 Injection, C1 esterase inhibitor (recombinant), ruconest, 10 units ( J0596 )

• 422 Injection, ceftolozane 50 mg and tazobactam 25 mg ( J0695 )

• 423 Injection, ceftazidime and avibactam, 0.5 g/0.125 g ( J0714 )

• 424 Injection, dalbavancin, 5mg ( J0875 )

• 425 Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron ( J1443 )

• 426 Injection, tbo-filgrastim, 1 microgram ( J1447 )

• 427 Injection, argatroban, 1 mg (for non-ESRD use) ( J0883 )

• 428 Injection, argatroban, 1 mg (for ESRD on dialysis) ( J0884 )

• 429 Injection, mepolizumab, 1 mg ( J2182 )

• 430 Injection, reslizumab, 1 mg ( J2786 )

• 431 Injection, factor x, (human), 1 i.u. ( J7175 )

• 432 Injection, bezlotoxumab, 10 mg ( J0565 )

• 433 Cinacalcet, oral, 1 mg, (for ESRD on dialysis) ( J0604 )

• 434 Injection, etelcalcetide, 0.1 mg ( J0606 )

• 435 Injection, eteplirsen, 10 mg ( J1428 )

• 436 Injection, immune globulin (cuvitru), 100 mg ( J1555 )

• 437 Injection, granisetron, extended-release, 0.1 mg ( J1627 )

• 438 Injection, hydroxyprogesterone caproate, (makena), 10 mg ( J1726 )

• 439 Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg ( J1729 )

• 440 Injection, nusinersen, 0.1 mg ( J2326 )

• 441 Ustekinumab, for intravenous injection, 1 mg ( J3358 )

• 442 Injection, aprepitant, 1 mg ( J0185 )

• 443 Injection, benralizumab, 1 mg ( J0517 )

• 444 Injection, cerliponase alfa, 1 mg ( J0567 )

• 445 Injection, burosumab-twza 1 mg ( J0584 )

• 446 Injection, c-1 esterase inhibitor (human), (haegarda), 10 units ( J0599 )

• 447 Injection, crotalidae immune f(ab')2 (equine), 120 mg ( J0841 )

• 448 Injection, edaravone, 1 mg ( J1301 )

• 449 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg ( J1454 )

• 450 Injection, guselkumab, 1 mg ( J1628 )

• 451 Injection, ibalizumab-uiyk, 10 mg ( J1746 )

• 452 Loxapine for inhalation, 1 mg ( J2062 )

• 453 Injection, rolapitant, 0.5 mg ( J2797 )

• 454 Injection, tildrakizumab, 1 mg ( J3245 )

• 455 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg ( J3304 )

• 456 Injection, triptorelin, extended-release, 3.75 mg ( J3316 )

• 457 Injection, vestronidase alfa-vjbk, 1 mg ( J3397 )

• 458 Injection, voretigene neparvovec-rzyl, 1 billion vector genomes ( J3398 )

• 459 Unclassified drug or biological used for esrd on dialysis ( J3591 )

• 460 Injection, emicizumab-kxwh, 0.5 mg ( J7170 )

• 461 Injection, meropenem and vaborbactam, 10mg/10mg (20mg) ( J2186 )

• 462 Riboflavin 5’-phosphate, ophthalmic solution, up to 3 ml ( J2787 )

• 463 Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron ( J1444 )

• 464 Injection, fremanezumab-vfrm, 1 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered) ( J3031 )

• 465 Injection, risperidone, (perseris), 0.5 mg ( J2798 )

• 466 Injection, omadacycline, 1 mg ( J0121 )

• 467 Injection, lanadelumab-flyo, 1 mg (code may be used for Medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered) ( J0593 )

• 468 Dexamethasone, lacrimal ophthalmic insert, 0.1 mg ( J1096 )

• 469 phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml ( J1097 )

• 470 Injection, plazomicin, 5 mg ( J0291 )

• 471 Injection, Patisiran, 0.1 mg ( J0222 )

• 472 Injection, ravulizumab-cwvz, 10 mg ( J1303 )

• 473 Injection, aripiprazole lauroxil, (aristada initio), 1 mg ( J1943 )

• 474 Injection, aripiprazole lauroxil, (aristada), 1 mg ( J1944 )

• 475 Injection, romosozumab-aqqg, 1 mg ( J3111 )

• 476 Injection, eravacycline, 1 mg ( J0122 )

• 477 Injection, levoleucovorin (khapzory), 0.5 mg ( J0642 )

• 478 Injection, brolucizumab-dbll, 1 mg ( J0179 )

• 479 Injection, givosiran, 0.5 mg ( J0223 )

• 480 Injection, deoxycholic acid, 1 mg ( J0591 )

• 481 Injection, lefamulin, 1 mg ( J0691 )

• 482 Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg ( J0742 )

• 483 Injection, crizanlizumab-tmca, 5 mg ( J0791 )

• 484 Injection, luspatercept-aamt, 0.25 mg ( J0896 )

• 485 Injection, cetirizine hydrochloride, 0.5 mg ( J1201 )

• 486 Injection, golodirsen, 10 mg ( J1429 )

• 487 Injection, immune globulin (xembify), 100 mg ( J1558 )

• 488 Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes ( J3399 )

• 489 Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg ( J7169 )

• 490 Injection, ferric derisomaltose, 10 mg ( J1437 )

• 491 Injection, brexanolone, 1 mg ( J1632 )

• 492 Injection, meloxicam, 1 mg ( J1738 )

• 493 Injection, eptinezumab-jjmr, 1 mg ( J3032 )

• 494 Injection, teprotumumab-trbw, 10 mg ( J3241 )

• 495 Injection, inebilizumab-cdon, 1 mg ( J1823 )

• 496 Injection, viltolarsen, 10 mg ( J1427 )

• 497 Injection, immune globulin (asceniv), 500 mg ( J1554 )

• 498 Injection, lumasiran, 0.5 mg ( J0224 )

• 499 Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg ( J1951 )

• 500 Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity ( J7168 )

• 501 Injection, cefiderocol, 10 mg ( J0699 )

• 502 Injection, cabotegravir and rilpivirine, 2mg/3mg ( J0741 )

• 503 Injection, evinacumab-dgnb, 5mg ( J1305 )

• 504 Injection, casimersen, 10 mg ( J1426 )

• 505 Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron ( J1445 )

• 506 Injection, trilaciclib, 1mg ( J1448 )

• 507 Injection, oritavancin (kimyrsa), 10 mg ( J2406 )

• 508 Injection, aducanumab-avwa, 2 mg ( J0172 )

• 509 Leuprolide injectable, camcevi, 1 mg ( J1952 )

• 510 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg ( J2506 )

• 511 Injection, remdesivir, 1 mg ( J0248 )

• 512 Injection, avalglucosidase alfa-ngpt, 4 mg ( J0219 )

• 513 Injection, anifrolumab-fnia, 1 mg ( J0491 )

• 514 Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis) ( J0879 )

• 515 Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) ( J0739 )

• 516 Injection, inclisiran, 1 mg ( J1306 )

• 517 Injection, immune globulin (cutaquig), 100 mg ( J1551 )

• 518 Injection, tezepelumab-ekko, 1 mg ( J2356 )

• 519 Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg ( J2779 )

• 520 Injection, plasminogen, human-tvmh, 1 mg ( J2998 )

• 521 Injection, triamcinolone acetonide (xipere), 1 mg ( J3299 )

• 522 Injection, sutimlimab-jome, 10 mg ( J1302 )

• 523 Injection, lanreotide, (cipla), 1 mg ( J1932 )

• 524 Injection, faricimab-svoa, 0.1 mg ( J2777 )

• 525 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg ( J0134 )

• 526 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg ( J0136 )

• 527 Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg ( J0173 )

• 528 Injection, vutrisiran, 1 mg ( J0225 )

• 529 Injection, amiodarone hydrochloride (nexterone), 30 mg ( J0283 )

• 530 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg ( J0689 )

• 531 Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg ( J0701 )

• 532 Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg ( J0703 )

• 533 Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg ( J0877 )

• 534 Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use) ( J0891 )

• 535 Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis) ( J0892 )

• 536 Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg ( J0893 )

• 537 Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use) ( J0898 )

• 538 Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis) ( J0899 )

• 539 Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg ( J1456 )

• 540 Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg ( J1574 )

• 541 Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg ( J1611 )

• 542 Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units ( J1643 )

• 543 Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg ( J1954 )

• 544 Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg ( J2021 )

• 545 Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg ( J2184 )

• 546 Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg ( J2247 )

• 547 Injection, midazolam hydrochloride (wg critical care), not therapeutically equivalent to j2250, per 1 mg ( J2251 )

• 548 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg ( J2272 )

• 549 Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg ( J2281 )

• 550 Injection, naloxone hydrochloride (zimhi), 1 mg ( J2311 )

• 551 Injection, risankizumab-rzaa, intravenous, 1 mg ( J2327 )

• 552 Injection, chloroprocaine hydrochloride, per 1 mg ( J2401 )

• 553 Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg ( J2402 )

• 554 Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg ( J3244 )

• 555 Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg ( J3371 )

• 556 Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg ( J3372 )

• 557 Injection, sodium thiosulfate (pedmark), 100 mg ( J0208 )

• 558 Injection, olipudase alfa-rpcp, 1 mg ( J0218 )

• 559 Injection, calcium gluconate, not otherwise specified, 10 mg ( J0612 )

• 560 Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg ( J0613 )

• 561 Injection, etranacogene dezaparvovec-drlb, per therapeutic dose ( J1411 )

• 562 Injection, eflapegrastim-xnst, 0.1 mg ( J1449 )

• 563 Injection, spesolimab-sbzo, 1 mg ( J1747 )

• 564 Chloroprocaine hcl ophthalmic, 3% gel, 1 mg ( J2403 )

• 565 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg ( J0137 )

• 566 Injection, allopurinol sodium, 1 mg ( J0206 )

• 567 Injection, alfentanil hydrochloride, 500 micrograms ( J0216 )

• 568 Injection, aztreonam, 100 mg ( J0457 )

• 569 Injection, bupivicaine, not otherwise specified, 0.5 mg ( J0665 )

• 570 Injection, clindamycin phosphate, 300 mg ( J0736 )

• 571 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg ( J0737 )

• 572 Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg ( J1576 )

• 573 Injection, esmolol hydrochloride, 10 mg ( J1805 )

• 574 Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg ( J1806 )

• 575 Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units ( J1811 )

• 576 Insulin (fiasp), per 5 units ( J1812 )

• 577 Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units ( J1813 )

• 578 Insulin (lyumjev), per 5 units ( J1814 )

• 579 Injection, metronidazole, 10 mg ( J1836 )

• 580 Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg ( J1921 )

• 581 Injection, furosemide (furoscix), 20 mg ( J1941 )

• 582 Injection, lenacapavir, 1 mg ( J1961 )

• 583 Injection, remimazolam, 1 mg ( J2249 )

• 584 Injection, nitroglycerin, 5 mg ( J2305 )

• 585 Injection, ublituximab-xiiy, 1mg ( J2329 )

• 586 Injection, phenylephrine hydrochloride, 20 micrograms ( J2371 )

• 587 Injection, phenylephrine hydrochloride (biorphen), 20 micrograms ( J2372 )

• 588 Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg ( J2427 )

• 589 Injection, phenobarbital sodium (sezaby), 1 mg ( J2561 )

• 590 Injection, vasopressin, 1 unit ( J2598 )

• 591 Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit ( J2599 )

• 592 Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms ( J2806 )

• 593 Injection, lecanemab-irmb, 1 mg ( J0174 )

• 594 Injection, rezafungin, 1 mg ( J0349 )

• 595 Injection, corticotropin (acthar gel), up to 40 units ( J0801 )

• 596 Injection, corticotropin (ani), up to 40 units ( J0802 )

• 597 Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg ( J0874 )

• 598 Daprodustat, oral, 1 mg, (for esrd on dialysis) ( J0889 )

• 599 Injection, olanzapine, 0.5 mg ( J2359 )

• 600 Injection, pegcetacoplan, intravitreal, 1 mg ( J2781 )

• 601 Injection, amisulpride, 1 mg ( J0184 )

• 602 Injection, velmanase alfa-tycv, 1 mg ( J0217 )

• 603 Injection, artesunate, 1 mg ( J0391 )

• 604 Injection, aripiprazole (abilify asimtufii), 1 mg ( J0402 )

• 605 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg ( J0688 )

• 606 Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv) ( J0751 )

• 607 Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified ( J0799 )

• 608 Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg ( J0873 )

• 609 Dexmedetomidine, oral, 1 mcg ( J1105 )

• 610 Injection, tofersen, 1 mg ( J1304 )

• 611 Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes ( J1412 )

• 612 Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose ( J1413 )

• 613 Injection, glycopyrrolate, 0.1 mg ( J1596 )

• 614 Injection, bumetanide, 0.5 mg ( J1939 )

• 615 Injection, nicardipine, 0.1 mg ( J2404 )

• 616 Injection, pegunigalsidase alfa-iwxj, 1 mg ( J2508 )

• 617 Injection, fluphenazine hcl, 1.25 mg ( J2679 )

• 618 Injection, risperidone (uzedy), 1 mg ( J2799 )

• 619 Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml ( J3401 )

• 620 Injection, hydroxocobalamin, intramuscular, 10 mcg ( J3425 )

• 621 Injection, aflibercept hd, 1 mg ( J0177 )

• 622 Injection, sodium thiosulfate (hope), 100 mg ( J0209 )

• 623 Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy ( J0577 )

• 624 Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy ( J0578 )

• 625 Injection, daxibotulinumtoxina-lanm, 1 unit ( J0589 )

• 626 Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg ( J0651 )

• 627 Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg ( J0652 )

• 628 Miglustat, oral, 65 mg ( J1202 )

• 629 Injection, cipaglucosidase alfa-atga, 5 mg ( J1203 )

• 630 Injection, elranatamab-bcmm, 1 mg ( J1323 )

• 631 Injection, fosaprepitant (focinvez), 1 mg ( J1434 )

• 632 Injection, motixafortide, 0.25 mg ( J2277 )

• 633 Injection, avacincaptad pegol, 0.1 mg ( J2782 )

• 634 Injection, risperidone (rykindo), 0.5 mg ( J2801 )

• 635 Injection, methylprednisolone sodium succinate, 5 mg ( J2919 )

• 636 Injection, talquetamab-tgvs, 0.25 mg ( J3055 )

• 637 Injection, hydroxocobalamin, intravenous, 25 mg ( J3424 )

• 638 Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity ( J7165 )

• 639 Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote) ( J0211 )

• 640 Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg ( J0687 )

• 641 Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg ( J0872 )

• 642 Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis) ( J0911 )

• 643 Injection, glycopyrrolate (glyrx-pf), 0.1 mg ( J1597 )

• 644 Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg ( J1598 )

• 645 Injection, infliximab-dyyb (zymfentra), 10 mg ( J1748 )

• 646 Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg ( J2183 )

• 647 Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg ( J2246 )

• 648 Injection, mirikizumab-mrkz, 1 mg ( J2267 )

• 649 Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms ( J2373 )

• 650 Injection, palonosetron hydrochloride (avyxa), not therapeutically equivalent to j2469, 25 micrograms ( J2468 )

• 651 Injection, pantoprazole sodium, 40 mg ( J2470 )

• 652 Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg ( J2471 )

• 653 Injection, secukinumab, intravenous, 1 mg ( J3247 )

• 654 Injection, toripalimab-tpzi, 1 mg ( J3263 )

• 655 Injection, betibeglogene autotemcel, per treatment ( J3393 )

• 656 Injection, lovotibeglogene autotemcel, per treatment ( J3394 )

• 657 Injection, adamts13, recombinant-krhn, 10 iu ( J7171 )